BRIDGE MEDICAL CONSULTING LIMITED

Company Registration Number:
07551547 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2023

Period of accounts

Start date: 01 January 2023

End date: 31 December 2023

BRIDGE MEDICAL CONSULTING LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2023

Balance sheet
Notes

BRIDGE MEDICAL CONSULTING LIMITED

Balance sheet

As at 31 December 2023


Notes

2023

2022


£

£
Fixed assets
Tangible assets: 3 7,224 2,462
Investments: 4 47,565 47,565
Total fixed assets: 54,789 50,027
Current assets
Debtors:   927,534 768,742
Cash at bank and in hand: 1,068,308 905,289
Total current assets: 1,995,842 1,674,031
Creditors: amounts falling due within one year:   (602,996) (470,988)
Net current assets (liabilities): 1,392,846 1,203,043
Total assets less current liabilities: 1,447,635 1,253,070
Total net assets (liabilities): 1,447,635 1,253,070
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 1,447,634 1,253,069
Shareholders funds: 1,447,635 1,253,070

The notes form part of these financial statements

BRIDGE MEDICAL CONSULTING LIMITED

Balance sheet statements

For the year ending 31 December 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 09 September 2024
and signed on behalf of the board by:

Name: P Gandhi
Status: Director

The notes form part of these financial statements

BRIDGE MEDICAL CONSULTING LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates. When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably. Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

Tangible fixed assets and depreciation policy

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases: Fixtures, fittings & equipment - 25% of written down value Computer equipment - 33.3% of written down value The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Other accounting policies

Foreign exchange Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

BRIDGE MEDICAL CONSULTING LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

2. Employees

2023 2022
Average number of employees during the period 2 3

BRIDGE MEDICAL CONSULTING LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

3. Tangible Assets

Total
Cost £
At 01 January 2023 28,316
Additions 7,052
At 31 December 2023 35,368
Depreciation
At 01 January 2023 25,854
Charge for year 2,290
At 31 December 2023 28,144
Net book value
At 31 December 2023 7,224
At 31 December 2022 2,462

BRIDGE MEDICAL CONSULTING LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

4. Fixed investments

Shares in group undertakings and participating interests £47,565 (2022: £47,565).